Scott Turner

Title: Scott Turner: Innovator in Pharmaceutical Science

Introduction

Scott Turner is a notable inventor based in Oakland, California, recognized for his contributions to pharmaceutical science. He holds three patents that focus on innovative treatments for various medical conditions, particularly those related to integrin inhibitors.

Latest Patents

One of Scott Turner's latest patents is titled "Dosage forms and regimens for amino acid compounds." This invention relates to dosage forms for daily administration of specific compounds that are useful for treating fibrosis, including idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP). Another significant patent is "Antibodies binding to α7β1 integrin antibodies and compositions thereof." This patent discloses pharmaceutical agents that activate integrin heterodimers, which are beneficial for treating diseases related to muscle malfunction, such as muscular dystrophies.

Career Highlights

Scott Turner is currently employed at Pliant Therapeutics, Inc., where he continues to advance his research and development efforts in the field of pharmaceuticals. His work focuses on creating innovative solutions that address critical health issues.

Collaborations

Throughout his career, Scott has collaborated with notable colleagues, including Martin Decaris and Eric Lefebvre. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Scott Turner exemplifies the spirit of innovation in the pharmaceutical industry, with his patents paving the way for new treatments that can significantly improve patient outcomes. His work at Pliant Therapeutics, Inc. continues to impact the field positively.